Hamps Bio IPO

NiftyTrader • December 11, 2024

Post Views: 68

Hamps Bio IPO opens for subscription on December 13, 2024 and closes on December 17, 2024. The allotment for the Hamps Bio IPO is expected to be finalized on Wednesday, December 18, 2024. Hamps Bio IPO will list on BSE SME with tentative listing date fixed as Friday, December 20, 2024.

Hamps Bio IPO price is ₹51 per share. The minimum lot size for an application is 2000 Shares. The minimum amount of investment required by retail investors is ₹102,000. The minimum lot size investment for HNI is 2 lots (4,000 shares) amounting to ₹204,000.

Hamps Bio IPO is a fixed price issue of Rs 6.22 crores. The issue is entirely a fresh issue of 12.2 lakh shares.

Hamps Bio IPO Details

IPO Date	December 13, 2024 to December 17, 2024
Listing Date	[.]
Face Value	₹10 per share
Price	₹51 per share
Lot Size	2000 Shares
Total Issue Size	1,220,000 shares (aggregating up to ₹6.22 Cr)
Fresh Issue	1,220,000 shares (aggregating up to ₹6.22 Cr)
Issue Type	Fixed Price Issue IPO
Listing At	BSE, NSE
Shareholding pre-issue	3,136,000
Share holding post issue	4,356,000
Market Maker portion	62,000 shares

Hamps Bio IPO Lot Size

Investors can bid for a minimum of 2000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	2000	₹102,000
Retail (Max)	1	2000	₹102,000
S-HNI (Min)	2	4000	₹204,000

Hamps Bio IPO Objectives

The Company intends to use its proceeds as follows:

Purchase of plant & machinery for FMCG division
Enhancing the visibility and awareness of the brand
General corporate purposes

About Hamps Bio

Incorporated in 2007, Hamps Bio Limited is engaged in the marketing and distribution of pharmaceutical products like tablets, syrups, capsules, injectables, oil, and nutritional supplements.

The company distributes its products through a network of over 50 distributors and e-commerce platforms, including Amazon (US, Canada, EU), Flipkart, and Jio Mart. Their pharma products are sold in 8 states and union territories, while Freeze-dried and Frozen products reach 6 countries and 22 states and union territories.

The company’s business is divided into two segments:

Pharmaceuticals: The company’s pharmaceutical products are marketed under the “Hamps” brand. The range includes tablets, syrups, capsules, injectables, and powders.
Freeze-dried and Frozen products: The FMCG division focuses on freeze-dried and frozen items under the “FzyEzy” brand. The company operates through both B2B and B2C models, offering products under its brand and through contract manufacturing. Freeze-dried and frozen products include Strawberry, Jamun, Mango, Beet Powder, Chikoo powder etc.

The company offers over 180 products across both segments. As of October 31, 2024, The company had 78 employees.

Competitive Strengths:

Brand Identity

Expert Leadership and Industry Experience Driving Strategic Business Growth

Distribution Network with an Expansive E-Retailing Presence

Wide and diversified range of products

Diversified, global customer base with long-standing relationships

Wide Geographical Presence

Hamps Bio Financial Information

Period Ended	31 Oct 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	644.00	514.77	395.87	364.31
Revenue	436.42	650.13	558.49	534.46
Profit After Tax	34.08	50.07	35.90	12.15
Net Worth	370.78	337.42	136.30	100.57
Reserves and Surplus	57.18	141.42	-13.70	-49.43
Total Borrowing	138.31	104.52	173.77	204.31
				Amount in ₹ Lakhs

Hamps Bio IPO Timeline (Tentative Schedule)

Hamps Bio IPO opens on December 13, 2024, and closes on December 17, 2024.

IPO Open Date	Friday, December 13, 2024
IPO Close Date	Tuesday, December 17, 2024
Basis of Allotment	Wednesday, December 18, 2024
Initiation of Refunds	Thursday, December 19, 2024
A credit of Shares to Demat	Thursday, December 19, 2024
Listing Date	Friday, December 20, 2024
Cut-off time for UPI mandate confirmation	5 PM on December 17, 2024